Ascent Group, LLC has filed its latest 13F-HR report with the SEC, revealing its investment holdings as of September 30, 2026. This filing is crucial as it provides insights into the company's investment strategies and portfolio composition, which can impact market dynamics.

Ascent Group, LLC is a Virginia-based investment firm incorporated in Delaware. The company primarily engages in asset management, focusing on various sectors, including technology and healthcare. The firm has been active in filing reports with the SEC, with its latest submission dated October 30, 2026, following a series of filings throughout the year.

The recent filing indicates that Ascent Group holds a total of 2,857 positions across various companies, with a reported total value of $3.34 billion. This diverse portfolio includes significant investments in well-known firms such as Abbott Laboratories, Alphabet Inc., and 3M Co. Notably, the filing lists multiple investment managers, including O'Shaughnessy, Assetmark, and Blackrock, which suggests a collaborative approach to asset management.

In the filing, Ascent Group's investment discretion is categorized as “OTR” (Other), indicating that the firm has control over the investment decisions for the listed holdings. This level of discretion allows the company to actively manage its investments, adapting to market changes and opportunities.

The impact of this filing may extend beyond Ascent Group itself. Investors and analysts will likely scrutinize the firm's strategic choices, particularly in sectors like technology and healthcare, which are currently experiencing significant growth. The presence of major competitors in these sectors could influence market trends and investment strategies across the board.

Ascent Group's filing does not specify future actions or upcoming votes related to its holdings. However, the firm’s ongoing engagement with the SEC and its transparent reporting practices highlight its commitment to regulatory compliance and investor communication.